Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by mercedesmanon Dec 20, 2022 12:57pm
173 Views
Post# 35182524

RE:RE:RE:RE:i-Dialco

RE:RE:RE:RE:i-Dialco AP.

Respect you as well.  I doubt Mgt will confirm anything that is currently under discussion. Especially given their history.

So we have to rely on common sense and/or speculation.

If I'm Medtronics, or Braun, or Baxter, or DaVita, and I wanted to compete with one of the dominent dialysis clinic players like Fesenius (who uses the NxStage machines), I would seek out world-wide control over any new equipment that comes along that works as well or better, and that might in fact, change the game).  Particularly if I already had a wide reaching distribution network in place.  Ideally i'd want to own the whole enchilada or if not piece out the relevent Division.   By comparision (to the big US players and Medtronics out of Dublin) Infomed is a relatively small Swiss Company.

We don't  know what value the other two parties place on some of Spectral's ace cards:
  • pre-existing Baxter relationships
  • FDA relationships (via JK?)
  • SAMI's will be needed for hemopurification (patented by Spectral worldwide)
  • Sam Amory (who apparently hasn't gone anywhere yet)
  • pre-existing customer ties (e.g ARC, VA, etc)
It's not as if Infomed has been selling DIMI's into Euprope in a big way...yet...that I know of.  Though the UAE did give it a positive endorsement.

So while iDialco, in it's current form, "seems to " pertain only to NA, I suspect that could change as things progress.

MM

<< Previous
Bullboard Posts
Next >>